Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India
· Delayed Price · Currency is INR 958.30
+0.65 (0.07%)
Jun 18, 2025, 3:30 PM IST
Zydus Lifesciences Employees
Zydus Lifesciences had 26,921 employees as of March 31, 2024. The number of employees increased by 3,895 or 16.92% compared to the previous year.
Employees
26,921
Change (1Y)
3,895
Growth (1Y)
16.92%
Revenue / Employee
8.63M INR
Profits / Employee
1.68M INR
Market Cap
963.62B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 9,741 |
| Cipla | 27,764 |
| Apollo Hospitals Enterprise | 83,147 |
| Mankind Pharma | 19,540 |
| Aurobindo Pharma | 26,015 |
| Alkem Laboratories | 17,432 |
| Fortis Healthcare | 12,088 |
Zydus Lifesciences News
- 6 days ago - Stocks to watch on June 12: Zydus Life, Adani Group, Tanla Platforms, HUL, Nazara Tech, MCX in focus - Business Upturn
- 7 days ago - Zydus receives USFDA EIR for Ankleshwar API facility with ‘No Action Indicated’ status - Business Upturn
- 8 days ago - Zydus receives EIR with VAI classification from USFDA for Dabhasa API facility - Business Upturn
- 13 days ago - Top stocks to buy today: Stock recommendations for June 5, 2025 - The Times of India
- 13 days ago - Analyst Upgrades Agenus As Zydus Deal Alleviates Cash Overhang - Benzinga
- 15 days ago - Zydus secures licensing rights for next-gen immuno-oncology platforms from US-based Agenus - Business Upturn
- 15 days ago - Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US - Financial Post
- 16 days ago - Zydus receives tentative USFDA approval for Rifaximin Tablets, 550 mg - Business Upturn